Findd.AI | $21,000,000 | (May 22, 2026)
CVRD Health | $5,000,000 | (May 22, 2026)
checker | $8,000,000 | (May 22, 2026)
Certified by Founder
Lodge
Ratio Therapeutics
start up
United States
- Boston, MA
- 02/12/2021
- Unknown
- $1,500,000
A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.
Ratio Therapeutics’ Trillium™ targeting scaffold combines pharmacokinetic modulation with best-in-class chelation technology to create proprietary small molecule targeting agents to attack a broad array of cancer targets. Our compounds accommodate imaging and therapeutic radioisotopes, ie "theranostics". The tunable nature of our platform combined with small-scale imaging trials in patients results in accelerated, de-risked compound selection.
- Industry Pharmaceutical Manufacturing
- Website https://ratiotx.com/
- LinkedIn https://www.linkedin.com/company/rat
Oorja Bio | $30,000,000 | (May 22, 2026)
Neurosoft Bioelectronics | $7,500,000 | (May 22, 2026)
Imperagen | $5,000,000 | (May 22, 2026)
Hark(1) | $700,000,000 | (May 22, 2026)
Dandelion Health | $14,000,000 | (May 22, 2026)
Century Health | $5,000,000 | (May 22, 2026)
shatterdome energy | $3,500,000 | (May 22, 2026)
LawX | $8,709,375 | (May 22, 2026)
Overwatch AI | $1,500,000 | (May 22, 2026)
Tribal(1) | $10,000,000 | (May 22, 2026)